Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-070-0 | CAS number: 25519-78-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2003-12-01 (date test substance was received) to 2004-11-05
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- : 1) No data on mitogenic stimulation or the metaphase-arresting substance, 2) Only 100 metaphase spreads scored per concentration.
- GLP compliance:
- no
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- p-fluorophenyl 4-piperidyl ketone hydrochloride
- EC Number:
- 247-070-0
- EC Name:
- p-fluorophenyl 4-piperidyl ketone hydrochloride
- Cas Number:
- 25519-78-2
- Molecular formula:
- C12H14FNO.ClH
- IUPAC Name:
- 4-(4-fluorobenzoyl)piperidine hydrochloride
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- Name of test material (as cited in study report): T 1047 ((4-fluorophenyl)(4-piperidinyl) methanone hydrochloride)
- Physical state: white powder
- Analytical purity: approx. 100%
- Purity test date: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
- Stability under test conditions: no data
- Storage condition of test material: at room temperature in the dark
- Other: received on 2003-12-01
Method
Species / strain
- Species / strain / cell type:
- other: human lymphocytes
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- 2 % rat liver homogenate metabolising system (S9)
- Test concentrations with justification for top dose:
- - Preliminary Toxicity Test: 0, 9.05, 19, 38, 76.15, 152.3, 304.6, 609.25, 1218.5 and 2437 μg/mL
The results of a preliminary toxicity test were used to set the concentration range for the chromosome aberration test:
- Group 1 (4(20)-hour without S9): 0, 150, 300, 600, 1200, 1600 and 2000 µg/mL (1200, 1600 and 2000 µg/mL were selected for metaphase analysis.)
- Group 2 (4(20)-hour with S9): 0, 150, 300, 600, 1200, 1600 and 2000 µg/mL (1200, 1600 and 2000 µg/mL were selected for metaphase analysis.)
- Group 3 (24-hour without S9): 0, 37.5, 75, 150, 300, 450 and 600 µg/mL (150, 300 and 450 µg/mL were selected for metaphase analysis.) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: MEM culture medium
- Justification for choice of solvent/vehicle: The test substance was found to be soluble in culture medium and therefore MEM was selected as the vehicle for this study.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation at 10 μg/mL for the 4(20) hour exposure (Group 2)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without metabolic activation; at 0.4 μg/mL for the 4(20) hour exposure and 0.2 μg/mL for the 24 hour continuous exposure (Groups 1 and 3 respectively)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
- in medium
DURATION:
- Exposure duration: 4 hours (Groups 1 and 2); 24 hours (Group 3)
- Expression time: 20 hours was stated as the expression period in the study report. However, the study report failed to specify the time of addition of a spindle inhibitor.
- Fixation time: 24 hours (all groups)
SPINDLE INHIBITOR: no data
STAIN: no data
NUMBER OF REPLICATIONS: Two cultures were tested per group. Except where there was the need to clarify an equivocal response, only one of the duplicate cultures was assessed for the incidence of cells with chromosome aberrations.
NUMBER OF CELLS EVALUATED:
100 metaphases per analyzed culture.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index (MI)
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- A positive response was recorded for a particular treatment if the % cells with aberrations, excluding gaps, markedly exceeded that seen in the concurrent control, either with or without a clear dose-relationship. For modest increases in aberration frequency a dose response relationship is generally required and appropriate statistical tests may be applied in order to record a positive response.
- Statistics:
- No data was provided in the study report on the statistical tests performed. However, P<0.001 was considered statistically significant.
Results and discussion
Test results
- Species / strain:
- other: human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: There was no significant change in pH at any of the dose levels used up to and including the 2437 µg/mL dose level.
- Effects of osmolality: There was no significant change in osmolarity at any of the dose levels used up to and including the 2437 µg/mL dose level.
- Evaporation from medium: no data
- Water solubility: no data
- Precipitation: no data
- Other confounding effects: the molecular weight of the test substance was 243.71 and therefore the maximum recommended dose level was 2437 µg/mL, which was equivalent to 10 mM.
RANGE-FINDING/SCREENING STUDIES:
A preliminary toxicity text was performed at dose levels of 9.5-2437 µg/mL using the same test design described above for the chromosome aberration assy. The mitotic index (MI) data showed evidence of dose-related test substance-induced toxicity in all three of the exposure groups. The dose response in Groups 1 and 2 was shown to be very steep. Microscopic assessment of the slides prepared from the treatment cultures showed that metaphase cells were present at up to 1218.5 µg/mL in Groups 1 and 2. In Group 3 the test substance was more toxic and metaphase cells were not observed at dose levels greater than 304.6 µg/mL. Therefore, the selection of the dose range for the chromosome aberration test was limited by toxicity for all three of the exposure groups.
COMPARISON WITH HISTORICAL CONTROL DATA:
All of the vehicle control cultures had frequencies of cells with chromosome aberrations within the expected range. The positive control substances induced statically significant increases in the frequency of cells with aberrations. It was therefore considered that the metabolic activation system was shown to be functional and the test mated itself was operating as expected.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
The test substance was seen to induce 54% mitotic inhibition at 2000 µg/mL in Group 1, 34% mitotic inhibition at 2000 µg/mL in Group 2 and 39% mitotic inhibition at 450 µg/mL in Group 3. A low MI value was seen for the Group 2 duplicate culture, which was considered to result in a slight underestimate of toxicity. Conversely, in Group 3, a high MI value for the duplicate culture of the 450 µg/mL dose group was also considered to result in a slight underestimate of toxicity. Therefore, it was considered that acceptable levels of toxicity were achieved in all cases. In all exposure groups the maximum dose level evaluated for chromosome aberrations was selected on the basis of toxicity. The test substance did not induce a statistically significant increase in the numbers of polyploid cells in any of the exposure groups. - Remarks on result:
- other: all strains/cell types tested
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results:
negative with and without metabolic activation
The test substance was evaluated for induction of chromosome aberrations in human lymphocytes. The test substance did not induce statistically significant increases in the frequency of cells with chromosome aberrations in the absence or presence of a liver enzyme metabolizing system after a 4(20)-hour exposure, or after a 24-hour exposure in the absence of metabolic activation. The test material was therefore considered to be non-clastogenic to human lymphocytes in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.